ALDH-2 inhibitors in the treatment of psychiatric disorders

Details for Australian Patent Application No. 2008323953 (hide)

Owner CV Therapeutics, Inc.

Inventors Overstreet, David; Diamond, Ivan

Agent Freehills

Pub. Number AU-A-2008323953

PCT Pub. Number WO2009/061924

Priority 60/985,911 06.11.07 US

Filing date 6 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061924 Priority application(s): WO2009/061924

5 August 2010 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc. 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323963-Liner for waste elimination systems

2008323947-Extracellular histones as biomarkers for prognosis and molecular targets for therapy